A stock that deserves closer examination: G-III Apparel Group Ltd (GIII)

While G-III Apparel Group Ltd has underperformed by -3.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GIII fell by -29.25%, with highs and lows ranging from $36.18 to $20.33, whereas the simple moving average fell by -18.31% in the last 200 days.

On June 09, 2025, Telsey Advisory Group Reiterated G-III Apparel Group Ltd (NASDAQ: GIII) to Market Perform. A report published by Telsey Advisory Group on March 14, 2025, Reiterated its previous ‘Market Perform’ rating for GIII. Telsey Advisory Group also reiterated GIII shares as ‘Market Perform’, quoting a target price of $38 on the company’s shares in a report dated December 11, 2024. Guggenheim Initiated an Buy rating on October 09, 2024, and assigned a price target of $36. Telsey Advisory Group resumed its ‘Market Perform’ rating for GIII, as published in its report on September 06, 2024. Telsey Advisory Group’s report from March 15, 2024 suggests a price prediction of $29 for GIII shares, giving the stock a ‘Market Perform’ rating. Barclays also rated the stock as ‘Underweight’.

Analysis of G-III Apparel Group Ltd (GIII)

Further, the quarter-over-quarter decrease in sales is -4.29%, showing a negative trend in the upcoming months.

One of the most important indicators of G-III Apparel Group Ltd’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 12.21% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.83, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and GIII is recording 721.25K average volume. On a monthly basis, the volatility of the stock is set at 3.31%, whereas on a weekly basis, it is put at 3.61%, with a loss of -3.71% over the past seven days. Furthermore, long-term investors anticipate a median target price of $25.25, showing growth from the present price of $23.08, which can serve as yet another indication of whether GIII is worth investing in or should be passed over.

How Do You Analyze G-III Apparel Group Ltd Shares?

The Apparel Manufacturing market is dominated by G-III Apparel Group Ltd (GIII) based in the USA. When comparing G-III Apparel Group Ltd shares with other companies under Consumer Cyclical, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 5.34, there is a growth in quarterly earnings of 37.68%.

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 14.25%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 99.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

GIII shares are owned by institutional investors to the tune of 99.70% at present.

Hot this week

Have you been able to find a good deal on Iterum Therapeutics Plc’s shares?

While Iterum Therapeutics Plc has underperformed by -5.23%, investors...

A closer look at Immuneering Corp (IMRX) is warranted

While Immuneering Corp has underperformed by -0.50%, investors are...

AHCO (AdaptHealth Corp) has impressive results

While AdaptHealth Corp has underperformed by -0.22%, investors are...

NovoCure Ltd (NVCR) did well last session?

While NovoCure Ltd has overperformed by 1.11%, investors are...

Do investors need to be concerned about Vericel Corp (VCEL)?

While Vericel Corp has overperformed by 1.84%, investors are...

Topics

Have you been able to find a good deal on Iterum Therapeutics Plc’s shares?

While Iterum Therapeutics Plc has underperformed by -5.23%, investors...

A closer look at Immuneering Corp (IMRX) is warranted

While Immuneering Corp has underperformed by -0.50%, investors are...

AHCO (AdaptHealth Corp) has impressive results

While AdaptHealth Corp has underperformed by -0.22%, investors are...

NovoCure Ltd (NVCR) did well last session?

While NovoCure Ltd has overperformed by 1.11%, investors are...

Do investors need to be concerned about Vericel Corp (VCEL)?

While Vericel Corp has overperformed by 1.84%, investors are...

Can you now get a good deal on Herbalife Ltd’s shares?

While Herbalife Ltd has underperformed by -2.43%, investors are...

American Superconductor Corp (AMSC) deserves closer scrutiny

While American Superconductor Corp has overperformed by 5.41%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.